Cognizant

CTSH · NYSE · Technology · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$19.4B$19.4B$19.7B$19.7B$21.1B$21.1B10.6% margin10.6% marginRevenueNet margin

Quarterly · last 8

Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26$4.9B$4.9B$4.8B$4.8B$4.8B$4.8B$5.0B$5.0B$5.1B$5.1B$5.2B$5.2B$5.4B$5.4B$5.4B$5.4B12.2% margin12.2% marginRevenueNet margin

Revenue (FY2025)

$21.1B

Net margin

10.6%

ROE

14.9%

Revenue CAGR (2y)

+4.4%

Profit CAGR (2y)

+2.4%

EPS (FY2025)

4.56

Net profit (FY2025)

$2.2B

Ask MarketChacha about CTSH

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

  • Jul 28, 2026

    Cognizant shares rose sharply after the company announced the launch of its new EMEA AI Unit on July 28 to help enterprises scale agentic AI adoption.

    source 1source 2· confidence: high
  • Jul 24, 2026

    No specific company catalyst or filing explains the move; Cognizant shares rose amid valuation appeal after a steep YTD decline, with earnings not due until July 29.

    · confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$21.1B$2.2B4.5610.6%14.9%
FY2024$19.7B$2.2B4.5111.3%15.5%
FY2023$19.4B$2.1B4.2111.0%16.1%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q1$5.4B$662.0M1.3912.2%
2025Q3$5.4B$274.0M0.565.1%
2025Q2$5.2B$645.0M1.3112.3%
2025Q1$5.1B$663.0M1.3413.0%
2024Q3$5.0B$582.0M1.1711.5%
2024Q2$4.8B$566.0M1.1411.7%
2024Q1$4.8B$546.0M1.1011.5%
2023Q3$4.9B$525.0M1.0410.7%
2023Q2$4.9B$463.0M0.919.5%
2023Q1$4.8B$580.0M1.1412.1%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.